• Colorectal cancer and the market for screening for this cancer is huge.
• I believe that Non-colonoscopy methods available to screening will become the norm as they are cheaper, and insurance companies will demand they be used first.
• Exact sciences and privately held EDP Biotech might win out in the battle for market share in the colorectal cancer screening space.

Read more HERE